Patents Assigned to Vaxlnnate Corporation
  • Publication number: 20130331548
    Abstract: Compositions that include at least one protein that activates a Toll-like Receptor and includes at least a portion of at least one Toll-like Receptor agonist and at least a portion of at least one papillomavirus suppressor binding protein, papillomavirus transforming protein and papillomavirus capsid protein can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can further include an adjuvant and a carrier protein.
    Type: Application
    Filed: August 20, 2013
    Publication date: December 12, 2013
    Applicant: Vaxlnnate Corporation
    Inventors: Valerian Nakaar, James W. Huleatt, Thomas J. Powell, Albert E. Price